{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:13:09Z","timestamp":1782504789876,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.thromres.2023.01.030","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T04:23:48Z","timestamp":1675311828000},"page":"11-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The role of anticoagulation clinics needs to be reassessed to include follow up of patients on direct oral anticoagulants"],"prefix":"10.1016","volume":"225","author":[{"given":"Armando","family":"Tripodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Chantarangkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.thromres.2023.01.030_bb0005","article-title":"Evolution of antithrombotic therapy for patients with atrial fibrillation: the prospective global GLORIA-AF registry program","volume":"6","author":"Beier","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2023.01.030_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12149","article-title":"Measuring Oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","author":"Baglin","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.030_bb0015","first-page":"462","article-title":"Position paper on laboratory testing for patients on direct oral anticoagulants. A consensus document from the SISET, FCSA, SIBioC and SIPMeL","volume":"16","author":"Tripodi","year":"2018","journal-title":"Blood Transfus."},{"key":"10.1016\/j.thromres.2023.01.030_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0038-1675816","article-title":"The non-vitamin K antagonist oral anticoagulants in heart disease: section V-special situations","volume":"119","author":"De Caterina","year":"2019","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.030_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2023.01.030_bb0030","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/jth.15884","article-title":"The myths behind DOAC measurement: analyses of prescribing information from different regulatory bodies and a call for harmonization","volume":"20","author":"Gosselin","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.030_bb0035","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1161\/CIR.0000000000000477","volume":"135","author":"Raval","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2023.01.030_bb0040","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1373\/clinchem.2005.049981","article-title":"Performance of clinical laboratories for DNA analyses to detect thrombophilia mutations","volume":"51","author":"Tripodi","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.thromres.2023.01.030_bb0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jth.13949","article-title":"Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme","volume":"16","author":"Tripodi","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.030_bb0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2016.11.061","article-title":"GLORIA-AF Investigators. The changing landscape for stroke prevention in AF: findings from the GLORIA-AF Registry Phase 2","volume":"69","author":"Huisman","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2023.01.030_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","volume":"63","author":"Reilly","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2023.01.030_bb0060","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jth.14001","article-title":"Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants","volume":"16","author":"Testa","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.030_bb0065","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/jth.14457","article-title":"Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants","volume":"17","author":"Testa","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.030_bb0070","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/jth.15677","article-title":"Monitoring of direct oral anticoagulants plasma levels for secondary stroke prevention","volume":"20","author":"Siedler","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.030_bb0075","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s11739-018-1854-6","article-title":"The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures","volume":"13","author":"Tripodi","year":"2018","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.thromres.2023.01.030_bb0080","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/bloodadvances.2020002335","article-title":"Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure","volume":"4","author":"Shaw","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.01.030_bb0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/CIRCULATIONAHA.116.022307","article-title":"Urgent need to measure effects of direct oral anticoagulants","volume":"134","author":"Weitz","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2023.01.030_bb0090","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.030_bb0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bjh.12566","article-title":"Correlating prothrombin time with plasma rivaroxaban level","volume":"163","author":"Rodgers","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2023.01.030_bb0100","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/bjh.16179","article-title":"International external quality assessment for measurements of direct oral anticoagulants: results and recommendations","volume":"188","author":"Hollestelle","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2023.01.030_bb0105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.01.030_bb0110","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","article-title":"Andexanet alfa for the reversal of factor Xa inhibitor activity","volume":"373","author":"Siegal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.01.030_bb0115","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/jth.13706","article-title":"The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran","volume":"15","author":"Simon","year":"2017","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:49:39Z","timestamp":1758736179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":23,"alternative-id":["S0049384823000373"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.01.030","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of anticoagulation clinics needs to be reassessed to include follow up of patients on direct oral anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}